Tiziana Life Sciences announces collaboration with Parexel Biotech to conduct phase 1b/2 clinical trial in patients with Crohn’s Disease
First Ever Study with take-home capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody Potential…
Month: November 2020
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, November 11, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today…
Bavarian Nordic Announces Interim Results for the First Nine Months of 2020
COPENHAGEN, Denmark, November 11, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
PCI Biotech third quarter 2020 results
Oslo (Norway), 11 November 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company,…
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
MENLO PARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:…
Organogenesis Holdings Inc. Announces Proposed Public Offering of Class A Common Stock
CANTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Golden Leaf Holdings to Report Third Quarter Earnings
TORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (“Golden Leaf” or the…
Keros Therapeutics Announces Proposed Public Offering of Common Stock
LEXINGTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
Vaxcyte to Present at Jefferies Virtual London Healthcare Conference
FOSTER CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc., formerly known as SutroVax,…
Turning Point Therapeutics to Participate in Jefferies Virtual London Healthcare Conference
SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference
EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…
Clinical Genomics to Present at 2020 Canaccord Genuity Virtual Medical Technologies & Diagnostics Forum
BRIDGEWATER, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) — Clinical Genomics (“CG” or the “Company”), a…
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results
LEXINGTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”)…
miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
Recently completed acquisition of Viridian Therapeutics, including an anti-IGF-1R monoclonal antibody, VRDN-001, for the potential…
Viela Bio Reports Third Quarter 2020 Financial Results and Program Highlights
Company to host investor conference call and webcast today at 5:00 pm EST GAITHERSBURG, Md.,…
Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal Residual Disease with clonoSEQ® Assay Across its Hematology and Oncology Portfolio
SEATTLE, Nov. 10, 2020 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology…
Adaptive Biotechnologies Reports Third Quarter 2020 Financial Results
SEATTLE, Nov. 10, 2020 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a…
Eyenovia Reports Third Quarter 2020 Financial Results
Company to host conference call and webcast today, November 10, at 4:30pm ET NEW YORK,…
PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine
PDS0203 prioritized for clinical development by PDS Biotech and Farmacore after successful meeting with Brazilian…
Phathom Pharmaceuticals Reports Third Quarter 2020 Results and Provides Update on Phase 3 Trials
Pivotal Phase 3 PHALCON-EE trial enrollment expected to complete before year-end 2020; top-line results expected…